Sernova Agrees on Terms to Gain Access to Proprietary Stem Cell Technology For the Treatment of Diabetes
July 15, 2014 06:00 ET
|
Sernova Corp.
LONDON, ONTARIO--(Marketwired - July 15, 2014) - Sernova Corp. (TSX VENTURE:SVA) a clinical stage company developing medical technologies for the long-term treatment of chronic metabolic...
Sernova Team Participates at Key US Life Sciences Event: 2014 BIO International Convention, San Diego
June 24, 2014 06:00 ET
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - June 24, 2014) - Sernova Corp. (TSX VENTURE:SVA), a clinical stage company developing disruptive medical technologies for the long-term treatment of...
Sernova's CEO Dr. Philip Toleikis Featured on BNN
June 20, 2014 06:00 ET
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - June 20, 2014) - Sernova Corp. (TSX VENTURE:SVA), a clinical stage company developing disruptive medical technologies for the long-term treatment of...
Sernova Provides Corporate Update and Results of 2014 Annual General Meeting
June 03, 2014 06:00 ET
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - June 3, 2014) - Sernova Corp. (TSX VENTURE:SVA), a clinical stage company developing medical technologies for the long-term treatment of chronic...
Sernova Receives Patent Allowance for Cell Pouch(TM) and Therapeutic Cell Transplantation Technologies
May 14, 2014 06:00 ET
|
Sernova Corp.
LONDON, ONTARIO--(Marketwired - May 14, 2014) - Sernova Corp. (TSX VENTURE:SVA), today announced that the Australian Patent Office has issued a Notice of Acceptance to Sernova for its...
Kevin Egan Joins Sernova as Chair Business Advisory Board
May 12, 2014 06:00 ET
|
Sernova Corp.
LONDON, ONTARIO--(Marketwired - May 12, 2014) - Sernova Corp. (TSX VENTURE:SVA) is pleased to announce that Mr. Kevin M. Egan, President, Borealis Biotechnology LLC, an international...
Sernova Announces Appointment of Nick Borrelly to Corporate Development Role
May 07, 2014 06:00 ET
|
Sernova Corp.
LONDON, ONTARIO--(Marketwired - May 7, 2014) - Sernova Corp. (TSX VENTURE:SVA) is pleased to announce that Mr. Nick Borrelly is joining Sernova in a consultant corporate development role....
New Diabetes Therapy to Replace Insulin Injections
April 24, 2014 10:30 ET
|
SERNOVA CORP
LONDON, Ontario, April 24, 2014 (GLOBE NEWSWIRE) -- Last week, a New York Times article by Elisabeth Rosenthal accused the medical industry of, "borrowing business models from technology companies...
Sernova's Cell Pouch(TM) Diabetes Clinical Trial Demonstrates Interim Safety and Biocompatibility
April 22, 2014 06:00 ET
|
Sernova Corp.
LONDON, ONTARIO--(Marketwired - April 22, 2014) - Sernova Corp. (TSX VENTURE:SVA), a clinical stage company developing medical technologies for the long-term treatment of chronic...
Sernova Announces Annual Meeting, Record Date and Adopts Advance Notice By-Law
February 26, 2014 06:00 ET
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - Feb. 26, 2014) - Sernova Corp. (TSX VENTURE:SVA), a clinical stage company developing medical technologies for the long-term treatment of chronic...